A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Clinical trial NCT03257644 · COMPLETED
Trial details
- NCT number
- NCT03257644
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-21
- Primary completion
- 2020-10-07
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.